ArticleSTAR protocols2021

A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.

Takuya Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.